Affiliation:
1. Universidade Federal de São Paulo
2. Hospital de Transplantes Euryclides de Jesus Zerbini
Abstract
Abstract
Introduction: Sepsis is one of the leading causes of mortality in patients with hematologic malignancies. Our aim is evaluate the impact of multimodal strategy on sepsis bundle compliance and in-hospital mortality in patients with hematologic malignancies.
Methods:We conducted a quasi-experimental study that included patients with hematologic malignancies and sepsis or septic shock, between January 1, 2017 and August 31, 2020. The study comprised two phases: phase 1, survey of sepsis and sepsis shock cases and reformulation of the sepsis team and sepsis bundle; phase 2, staff training, monthly meetings of the sepsis team and feedback for care teams. The followup of patients was for 30 days, during hospitalization, or until death. Data were analyzed with descriptive and inferential statistics, with a 95% significance interval. And the tests considered a 5% significance level.
Results: A total of 329 (42.5%) patients were included. The proportion of sepsis was 241 (73.3%) and septic shock 88 (26.7%). We observed an increase in the 3h-bundle compliance in the phase 2 (86.8%), compared to the phase 1 (71.3%), with p=0.001. The in-hospital mortality was lower in the 2nd phase (38.2%), compared to the first phase (51.5%), with p=0.024. These results were mainly observed in cases of sepsis identified in the wards.
Conclusions:The multimodal strategy had an impact on increasing the rate of compliance to the sepsis bundle. In-hospital mortality significantly reduced in the intervention phase of the study.
Publisher
Research Square Platform LLC
Reference18 articles.
1. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of America;Freifeld AG;Clin Infect Dis,2011
2. The epidemiology of sepsis in Brazilian intensive care units (the Sepsis PREvalence Assessment Database, SPREAD): an observational study;Machado FR;Lancet Infect Dis.,2017
3. Effectiveness of treatments for severe sepsis: A prospective, multicenter, observational study;Ferrer R;Am J Respir Crit Care Med,2009
4. Boucher JE, Carpenter D. Sepsis: Symptoms, Assessment, Diagnosis, and the Hour-1 Bundle in Patients With Cancer. Clin J Oncol Nurs. 2020 Feb 1;24(1):99–102.
5. Survival in neutropenic patients with severe sepsis or septic shock;Legrand M;Crit Care Med,2012